Literature DB >> 17550467

Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection.

Isdore Chola Shamputa1, Armand Van Deun, Md Abdul Hamid Salim, Md Anwar Hossain, Krista Fissette, Pim de Rijk, Leen Rigouts, Françoise Portaels.   

Abstract

OBJECTIVE: To determine the relative frequencies of reinfection vs. reactivation or treatment failure in patients from a high tuberculosis incidence setting with a low prevalence of HIV infection.
METHOD: We performed DNA fingerprinting on serial isolates from one and multiple TB episodes from 97 retreatment patients; 35 patients had been previously cured, whereas 62 had not.
RESULTS: DNA fingerprinting patterns of recurrence Mycobacterium tuberculosis isolates of 5 of the 35 previously cured patients did not match with those of the corresponding initial isolates, indicating reinfection. We did not document reinfection during treatment. Isolates from each of the remaining 30 previously cured patients had identical DNA fingerprinting results, indicating reactivation. DNA fingerprinting patterns of isolates from the 62 patients with persistently positive sputum smears were identical, suggesting treatment failure.
CONCLUSION: These findings suggest that reinfection is not a common cause of relapse and treatment failure in this rural predominantly HIV-free population despite the high incidence of TB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550467     DOI: 10.1111/j.1365-3156.2007.01840.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  4 in total

1.  How host heterogeneity governs tuberculosis reinfection?

Authors:  M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

2.  Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Authors:  Timothy Lahey; Siddharth Sheth; Mecky Matee; Robert Arbeit; C Robert Horsburgh; Lillian Mtei; Todd Mackenzie; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  Genetic diversity of Mycobacterium tuberculosis isolates from a tertiary care tuberculosis hospital in South Korea.

Authors:  Isdore Chola Shamputa; Jongseok Lee; Caroline Allix-Béguec; Eun-Jin Cho; Ji-im Lee; Vignesh Rajan; Eun Gae Lee; Jin Hong Min; Matthew W Carroll; Lisa C Goldfeder; Jin Hee Kim; Hyung Seok Kang; Soohee Hwang; Seok-Yong Eum; Seung Kyu Park; Hyeyoung Lee; Philip Supply; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  J Clin Microbiol       Date:  2009-12-16       Impact factor: 5.948

Review 4.  Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.

Authors:  Xueying Zhang; Qi Xie; Ziyu Ye; Yanyun Li; Zhengping Che; Mingyuan Huang; Jincheng Zeng
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.